CAPRISA CASCADE clinical trials site in Durban for HIV and women's health
Official title: CAPRISA CASCADE Clinical Trials Network Clinical Research Site
Funded at Centre/aids Programme/res/south Africa · NIH-11115844 · Data updated 2026-11-12
This clinic runs HIV prevention and care trials aimed mostly at young women and people living with HIV in KwaZulu-Natal.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Centre/aids Programme/res/south Africa NIH-funded |
| Lab location | 1 site (Durban, SOUTH AFRICA) |
| Project start | September 5, 2023 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $216,000 |
| NIH project number | 5UG1CA284671-03 |
| Project ID | NIH-11115844 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living in or near Durban/KwaZulu-Natal—especially young women or others at risk for HIV or living with HIV who meet a trial's eligibility rules.
✕Less likely to help
People who live far from the area, do not meet specific trial requirements, or are not at risk for or living with HIV are unlikely to benefit directly from participation.
What this research studies
This CAPRISA site in Durban provides clinic space, staff, and operations to run practical HIV trials in a region with high HIV rates. The team recruits participants (often young women), conducts regular clinic visits, offers HIV testing and treatment linkage, and collects medical data and samples as part of trials. The site supports multiple studies focused on preventing HIV, understanding how the virus affects the body, and improving care for women living with HIV. Community engagement and long-term follow-up are part of how they run trials to make results useful locally.
Why it matters
Potential benefit: If successful, the work could speed access to better HIV prevention tools and care approaches for people in this high-burden region.
How similar studies have gone: CAPRISA and other HIV research groups have previously produced successful prevention and treatment findings, so this work builds on an established track record.
Where this research is happening
-
Centre/aids Programme/res/south Africa
Durban, South Africa Active
Researchers
- Principal investigator: Naicker, Nivashnee — Centre/aids Programme/res/south Africa
- Study coordinator: Naicker, Nivashnee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.